10x Genomics Denmark ApS
CVR 40243224 · Private limited company (ApS) · Active · Low risk
10x Genomics Denmark ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 7 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 974k and a net result of DKK 155k. CEO: Adam Samuel Taich, James Sears Bryant.
Bankruptcy risk for 10x Genomics Denmark ApS
0.0 × the average (1.41%) · higher risk than 33% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 40243224
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (7 years)
- Address
- Lyngbyvej 20
2100 København Ø - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 52k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 7 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 62.4% |
| Current ratio | 266% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 8 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 184 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 3.4m | DKK 3.4m | DKK 2.1m |
| Net profit | DKK 155k | DKK 183k | DKK -587k |
| Equity | DKK 974k | DKK 819k | DKK 635k |
| Total assets | DKK 1.6m | DKK 1.4m | DKK 2.3m |
| Cash | DKK 1.5m | DKK 754k | – |
| Short-term debt | DKK 587k | DKK 611k | – |
| Tax owed | – | DKK 0 | – |
| Avg. employees | – | 2 | – |
Latest annual report: Reporting class B, micro-undertaking · auditor's statement: No audit assistance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 135 | ||
| 1 Jan 2024 – 31 Dec 2024 | 142 | ||
| 1 Jan 2023 – 31 Dec 2023 | 179 | ||
| 1 Jan 2022 – 31 Dec 2022 | 174 | ||
| 1 Jan 2021 – 31 Dec 2021 | 174 | ||
| 1 Jan 2020 – 31 Dec 2020 | 175 | ||
| 31 Jan 2019 – 31 Dec 2019 | 113 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Adam Samuel Taich | Current | |
| CEO | James Sears Bryant | Current | |
| CEO | Justin John McAnear | ||
| CEO | Søren Nyboe Jakobsen | ||
| CEO | Eric Stewart Whitaker | ||
| Board | Søren Nyboe Jakobsen | ||
| Board | Sunil Kumar Saini | ||
| Board | Sebastian Hartmut Springer | ||
| Board | Søren Fogh Aagaard | ||
| Owner (100%) | 10x Genomics, Inc. | Current | |
| Owner (20%) | Sunil Kumar Saini | ||
| Owner (25%) | MOLIOR HOLDING ApS | ||
| Owner (20%) | Hadrup BioMed Holding ApS | ||
| Owner (20%) | Sebastian Hartmut Springer | ||
| Owner (5%) | JCBS Holding GmbH | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Sunil Kumar Saini | Current | |
| Founder | MOLIOR HOLDING ApS | Current | |
| Founder | Hadrup BioMed Holding ApS | Current | |
| Founder | Sebastian Hartmut Springer | Current | |
| Founder | JCBS Holding GmbH | Current |
The CEOs' other companies
Søren Nyboe Jakobsen – 5 other companies
- BUILD THERAPEUTICS ApS Opløst
- Combotope Therapeutics ApS Active
- MOLIOR HOLDING ApS Active
- Tetramer Store ApS Active
- p.A.c. ApS Opløst
Address history (2 moves)
| Lyngbyvej 20, 2100 København Ø | |
| c/o Scion DTU A / S, Diplomvej 381, 2800 Kongens Lyngby | |
| c/o Søren Jakobsen, Vintervej 6, 1., 2920 Charlottenlund |
Former names
| 10x Genomics Denmark ApS | – now |
| Tetramer Shop ApS | – |
Other companies at the same address
- 3B HERNING ApS Bankrupt
- ADMINISTRATION & SERVICE ApS Bankrupt
- AFVIKLINGSSELSKABET AF 2. APRIL 2007 NR. 1 ApS Bankrupt
- ANPARTSELSKABET AF 20.09.2012 ApS Bankrupt
- ARRISCO INTERNATIONAL CONSULT - STATSAUTORISERET REVISIONSANPARTSSELSKAB Bankrupt
- Airtrans Holding ApS Bankrupt
- BAKED2DAY ApS Bankrupt
- BATTERIEKSPERTEN ApS Bankrupt
- BIG WI-FI A/S Bankrupt
- Byens slagter kbh ApS Bankrupt
- COLUMBUS CONSULT ApS Bankrupt
- Complex Transport Danmark ApS Bankrupt
- Copenhagen Laser Clinic ApS Bankrupt
- DANLOGIC A/S Bankrupt
- DK RETAIL PAYMENTS ApS Bankrupt
- DOCEA INTERNATIONAL ApS Bankrupt
- Dane Import ApS Bankrupt
- Dansk Elektronik Engros ApS Bankrupt
- EE INVEST ApS - TRIER Bankrupt
- FAF INVEST NO 14 ApS Bankrupt
- FLUID TRADING ApS Bankrupt
- FOOD FORWARD ApS Bankrupt
- FRAM A/S Bankrupt
- GOCAST ApS Bankrupt
- GREENWOOD ASSET MANAGERS ApS Bankrupt
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about 10x Genomics Denmark ApS
Has 10x Genomics Denmark ApS gone bankrupt?
No, 10x Genomics Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of 10x Genomics Denmark ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of 10x Genomics Denmark ApS?
Adam Samuel Taich, James Sears Bryant are the CEOs of 10x Genomics Denmark ApS.
When was 10x Genomics Denmark ApS founded?
10x Genomics Denmark ApS was founded on 31 January 2019.
What is the equity of 10x Genomics Denmark ApS?
Equity was DKK 974k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.